GlassScriptPhysician profile
Bo-Kyu Kim
NPI 1477896553
$1,995.50
in general payments reported to CMS, 2019-2025
10 companies · $460 in 2025
The $460 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.40 · 2020: $13.13 · 2021: $1.83 · 2022: $20.90 · 2023: $30.04 · 2024: $1,433 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $966 · Food and Beverage: $948 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $966.25 |
| Food and Beverage | $948.25 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,142.74 | 2021-2024 | |
| Medical Device Business Services, INC. | $432.32 | 2025 | Linx Reflux Management System |
| Boston Scientific Corporation | $144.30 | 2024 | Spyglass Discover |
| Merck Sharp & Dohme LLC | $89.10 | 2019-2025 | Bridion |
| Davol INC. | $88.38 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $29.47 | 2024 | Linx Reflux Management System |
| Conmed Corporation | $25.50 | 2024 | Visiclear, Conmed Specimen Retrieval, Airseal |
| Pacira Pharmaceuticals Incorporated | $15.59 | 2023 | Iovera, Zilretta, Exparel |
| Eagle Pharmaceuticals, INC. | $14.45 | 2023 | |
| Ekos Corporation | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bo-Kyu Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.